外源性Ang-1与miR-210共感染的内皮祖细胞腔内移植促进糖尿病慢性下肢缺血血管新生

doi:10.16352/j.issn.1001-6325.2026.01.0046

基础医学与临床 ›› 2026, Vol. 46 ›› Issue (1): 46-55.doi: 10.16352/j.issn.1001-6325.2026.01.0046

外源性Ang-1与miR-210共感染的内皮祖细胞腔内移植促进糖尿病慢性下肢缺血血管新生

李春孟^1,2*, 孙慧艳^2,3, 郑祥坚^1,2, 谢尚尚^1,2, 林德永^1,2, 刘子田^1,2

温州市中心医院(温州医科大学定理临床学院) 1.血管外科;
2.泛血管疾病管理实验室;
3.内分泌科,浙江温州 325000

收稿日期:2025-02-27 修回日期:2025-04-28 出版日期:2026-01-05 发布日期:2025-12-29
通讯作者: ^*lercermer@yeah.net
基金资助:
浙江省卫生健康委医药卫生科技计划(2020KY295)

Endovascular transplantation of endothelial progenitor cells co-infected with exogenous Ang-1 and miR-210 promotes angiogenesis in diabetic chronic lower limb ischemia

LI Chunmeng^1,2*, SUN Huiyan^2,3, ZHENG Xiangjian^1,2, XIE Shangshang^1,2, LIN Deyong^1,2, LIU Zitian^1,2

1. Department of Vascular Surgery;
2. Laboratory of Pan-Vascular Disease Management;
3. Department of Endocrinology, the Dingli Clinical Institute of Wenzhou Medical University (Wenzhou Central Hospital), Wenzhou 325000, China

Received:2025-02-27 Revised:2025-04-28 Online:2026-01-05 Published:2025-12-29
Contact: ^*lercermer@yeah.net

摘要/Abstract

摘要： 目的探讨血管生成素-1(Ang-1)与微小RNA-210(miR-210)共修饰内皮祖细胞(EPCs)的抗凋亡、迁移及促血管新生能力,为糖尿病性慢性下肢缺血治疗提供实验依据。方法分离SD大鼠骨髓EPCs,通过Dil-ac-LDL/FITC-UEA-1双荧光染色及流式细胞测量术(CD34⁺/CD133⁺)鉴定表型。构建Ang-1和miR-210 过表达慢病毒载体,并通过慢病毒感染EPCs,RT-qPCR检测基因表达。在高糖低氧(22.0mmol/L 葡萄糖,3% O₂)条件下,采用Annexin V/PI 染色、Transwell小室法及ECMatrix胶血管生成实验,分别评估细胞凋亡率、迁移能力及成管效率。建立大鼠后肢缺血模型,腔内移植修饰EPCs后28 d,行CD31免疫组化检测微血管密度,Western blot分析Ang-1/Tie2/PI3K/AKT通路相关蛋白质表达。结果成功培养鉴定EPCs,共感染组 Ang-1 和 miR-210表达量分别较对照组升高3.88倍和4.21倍(P＜0.01)。高糖低氧环境下,共感染组EPCs凋亡率(10.84%)显著低于对照组(26.22%,P＜0.01),迁移细胞数(78.3±5.2)提高3.64倍(P＜0.01),血管分支数(15.6±1.8)增加3.7 倍(P＜0.01)。动物实验显示,共感染组微血管密度(97.7±12.5)较对照组(26.3±18.4)提高 3.71 倍(P＜0.05),缺血组织中 Ang-1、VEGF、p-AKT 及 p-VEGFR 表达显著上调(P＜0.05)。结论 Ang-1与miR-210共修饰可显著增强EPCs在糖尿病缺血微环境中的存活能力与促血管新生功能,其机制与激活Ang-1/Tie2/PI3K/AKT通路密切相关。

关键词: 内皮祖细胞, 血管生成素, 微小RNA, 慢性下肢缺血

Abstract: Objective To investigate the co-modification of endothelial progenitor cells(EPCs) by angiopoietin-1 (Ang-1) and microRNA-210 (miR-210). The anti-apoptosis, migration and angiogenesis promotion of endothelial progenitor cells (EPCs) provide experimental basis for the treatment of diabetic chronic lower limb ischemia. Methods EPCs in bone marrow of SD rats were isolated and phenotype was identified by Dil-ac-LDL/FITC-UEA-1 double fluorescence staining microscopy and by flow cytometry (for checking CD34⁺/CD133⁺). Ang-1 and miR-210 over-expressed lentiviral vectors were constructed and infected into EPCs, gene expression was detected by RT-qPCR. Annexin V/PI staining, Transwell assay and ECMatrix gel angiogenesis assay were used to evaluate cell apoptosis rate, migration and tube formation in medium with high glucose and low oxygen (22.0 mmol/L glucose, 3% O₂) conditions. The rat hind limb ischemia model was established; And 28 days after intracavity transplantation modified EPCs; Micro-vascular density was detected by CD31 immuno-histochemistry; And Ang-1/Tie2/PI3K/AKT path-related protein expression was analyzed by Western blot. Results EPCs was successfully cultured and identified. The expression of Ang-1 and miR-210 in the co-transfection group was 3.88 times and 4.21 times higher than those in the control group respectively(P＜0.01). The EPCs apoptosis rate (10.84%) in the co-transfection group was significantly lower than that in the control group (26.22%, P＜0.01). The counting of migrating cells (78.3±5.2) was increased by 3.64 times (P＜0.01). The quantity of vascular branches (15.6±1.8) was increased by 3.7 times (P＜0.01). The microvascular density (97.7±12.5) in the cotransfection group was 3.71 times higher than that in the control group (26.3±18.4,P＜0.05) and the expression of Ang-1, VEGF, P-Akt and P-VEGFR in ischemic tissue was significantly up-regulated(P＜0.05). Conclusions The co-modification of Ang-1 and miR-210 can significantly improve the survival of EPCs in diabetic ischemic micro-environment and promote angiogenesis. Its mechanism is closely related to the activation of Ang-1/Tie2/PI3K/AKT pathway.

Key words: endothelial progenitor cell, angiopoietin, microRNA, chronic lower limb ischemia

中图分类号:

Q25
R543.5

李春孟, 孙慧艳, 郑祥坚, 谢尚尚, 林德永, 刘子田. 外源性Ang-1与miR-210共感染的内皮祖细胞腔内移植促进糖尿病慢性下肢缺血血管新生[J]. 基础医学与临床, 2026, 46(1): 46-55.

LI Chunmeng, SUN Huiyan, ZHENG Xiangjian, XIE Shangshang, LIN Deyong, LIU Zitian. Endovascular transplantation of endothelial progenitor cells co-infected with exogenous Ang-1 and miR-210 promotes angiogenesis in diabetic chronic lower limb ischemia[J]. Basic & Clinical Medicine, 2026, 46(1): 46-55.

参考文献

[1]Pyšná A, Bém R, Němcová A, et al. Endothelial progenitor cells biology in diabetes mellitus and peripheral arterial disease and their therapeutic potential[J]. Stem Cell Rev Rep, 2019,15:157-165.
[2]Norgren L, Weiss N, Nikol S, et al. PLX-PAD cell treatment of critical limb ischaemia: rationale and design of the PACE trial[J]. Eur J Vasc Endovasc Surg, 2019,57:538-545.
[3]Ledford KJ, Murphy N, Zeigler F, et al. Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases[J]. Stem Cell Res Ther, 2015,13;6:25. doi:10.1186/s13287-015-0007-3.
[4]Liang TW, Jester A, Motaganahalli RL, et al. Autologous bone marrow mononuclear cell therapy for critical limb ischemia is effective and durable[J]. J Vasc Surg, 2016,63:1541-1545.
[5]Altabas V, Altabas K, Kirigin L, et al. Endothelial progenitor cells (EPCs) in ageing and age-related diseases: How currently available treatment modalities affect EPC biology, atherosclerosis, and cardiovascular outcomes[J]. Mech Ageing Dev, 2016,159:49-62.
[6]Song Y, Yang J, Li T, et al. CD34⁺ cell-derived fibroblast-macrophage cross-talk drives limb ischemia recovery through the OSM-ANGPTL signaling axis[J]. Sci Adv, 2023,9:eadd2632. doi:10.1126/sciadv.add2632.
[7]Zhu QQ, Li DL, He YY, et al. Advanced glycation end-products downregulate HoxA9EC through activation of nuclear factor Kappa B by reciprocal interaction[J]. J Vasc Res, 2017,54:226-234.
[8]Xiao F, Qiu H, Zhou L, et al. WSS25 inhibits Dicer, downregulating microRNA-210, which targets Ephrin-A3, to suppress human microvascular endothelial cell (HMEC-1) tube formation[J]. Glycobiology, 2013,23:524-535.
[9]Wang Y, Fan L, Meng X, et al. Transplantation of IL-10-transfected endothelial progenitor cells improves retinal vascular repair via suppressing inflammation in diabetic rats[J]. Graefes Arch Clin Exp Ophthalmol, 2016,254:1957-1965.
[10]Zhao Y, Yu B, Wang Y, et al. Ang-1 and VEGF: central regulators of angiogenesis[J]. Mol Cell Biochem, 2024:23. doi:10.1007/s11010-024-05010-3.
[11]Saharinen P, Eklund L, Alitalo K, et al. Therapeutic targeting of the angiopoietin-TIE pathway. [J] Nat Rev Drug Discov, 2017,16:635-661.
[12]Guan Y, Song X, Sun W, et al. Effect of hypoxia-induced microRNA-210 expression on cardiovascular disease and the underlying mechanism[J]. Oxid Med Cell Longev, 2019,2019:4727283. doi:10.1155/2019/4727283.
[13]Ren CX, Leng RX, Fan YG, et al. MicroRNA-210 and its theranostic potential[J]. Expert Opin Ther Targets, 2016,20:1325-1338.
[14]Canjuga D, Steinle H, Mayer J, et al. Homing of mRNA-modified endothelial progenitor cells to inflamed endothelium[J]. Pharmaceutics, 2022,14:1194. doi:10.3390/pharmaceutics14061194.
[15]Zan T, Li H, Du Z, et al. Enhanced endothelial progenitor cell mobilization and function through direct manipulation of hypoxia inducible factor-1α[J]. Cell Biochem Funct, 2015,33:143-149.

外源性Ang-1与miR-210共感染的内皮祖细胞腔内移植促进糖尿病慢性下肢缺血血管新生

Endovascular transplantation of endothelial progenitor cells co-infected with exogenous Ang-1 and miR-210 promotes angiogenesis in diabetic chronic lower limb ischemia

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	安信, 贾麟, 马吾苏木·马木特, 黄志鹏, 卡哈尔曼·斯拉木, 热夏提·热合曼, 海日拉·吾拉木, 库尔班江·阿布力克木, 加素尔·巴吐尔. ANGPT1影响小鼠前列腺癌细胞系RM-1增殖、侵袭及血管生成[J]. 基础医学与临床, 2025, 45(9): 1165-1172.
[2]	于华惠, 杜智勇, 焦晓璐, 吕倩雯, 杨云云, 韩丽杰, 秦彦文. 血管生成素样蛋白8通过激活p53信号通路促进平滑肌细胞凋亡[J]. 基础医学与临床, 2025, 45(7): 882-888.
[3]	张宗丽, 李涛, 马菁文, 张嘉鑫, 李兴朝, 席世兵. 氧浓度变化对人肺动脉内皮细胞中ANGPTL8表达的影响[J]. 基础医学与临床, 2025, 45(1): 12-19.
[4]	何华美, 陆巍. miR-135a-5p通过调控CXCL12表达降低吗啡耐受[J]. 基础医学与临床, 2024, 44(5): 665-672.
[5]	韩丽杰, 胡朝伟, 于华惠, 秦彦文. 血管生成素样蛋白8在心血管疾病发病中作用的研究进展[J]. 基础医学与临床, 2024, 44(4): 544-547.
[6]	韩晶晶, 王萱若, 张欣怡, 高涵, 成秀梅, 杨留才, 曲学彬. 转录因子CREB调节小鼠CD4⁺淋巴细胞中miR-30a的表达[J]. 基础医学与临床, 2023, 43(8): 1229-1233.
[7]	王帆, 邓勇志. 微小RNAs在心肌肥厚中作用和分子机制的研究进展[J]. 基础医学与临床, 2023, 43(7): 1167-1170.
[8]	杨孟迪, 丁雨露, 王玉洁, 何风英, 孙琳楠, 甄东户. MicroRNA在糖尿病性骨质疏松症中作用的研究进展[J]. 基础医学与临床, 2023, 43(2): 311-316.
[9]	查娜, 郝丹丹, 李天柱. microRNAs通过Hippo通路抑制肝细胞癌发生的研究进展[J]. 基础医学与临床, 2023, 43(12): 1871-1875.
[10]	邱立彬, 张新才, 赵倩. LncRNA DANCR靶向miR-3646减轻缺氧诱导的大鼠心肌细胞系H9c2的损伤[J]. 基础医学与临床, 2023, 43(1): 144-151.
[11]	阮锋, 李贺伟, 龚艳琳, 刘佳丽, 刘平. 过表达miR-217调控EZH2促进骨质疏松模型小鼠BM-MSCs成骨分化[J]. 基础医学与临床, 2022, 42(9): 1406-1413.
[12]	孙秋菊, 焦晓璐, 于华惠, 李凡, 吕倩雯, 王钰, 秦彦文. 血管生成素样蛋白8促进大鼠主动脉血管平滑肌细胞表型转化[J]. 基础医学与临床, 2022, 42(5): 745-751.
[13]	王玉敏, 陈济超, 王洪权, 王金华, 唐博. MicroRNAs靶向脂代谢重编程参与肝细胞癌发生的研究进展[J]. 基础医学与临床, 2022, 42(12): 1930-1934.
[14]	张传西, 张宇, 郭莎莎, 厉菁, 袁义强, 王明杰. 血清miR-181b和miR-27a表达与颈动脉粥样硬化程度相关[J]. 基础医学与临床, 2021, 41(8): 1133-1138.
[15]	方涛, 杨婉浠, 李昕, 丛志成, 张沛宗, 祁泉, 宋兵. 负载血管生成素1的聚乳酸羟基乙酸-聚乙二醇纳米微粒促进大鼠心肌梗死后心肌修复[J]. 基础医学与临床, 2021, 41(8): 1114-1120.